Low testosterone in a 25-year-old is fundamentally different from low testosterone in a 55-year-old. In older men, gradual age-related decline is the most common explanation. In young men, low testosterone is almost always a sign of something else, a reversible condition, a lifestyle factor, or an underlying pathology that requires identification rather than testosterone replacement as the first response.
A young man diagnosed with low testosterone deserves a more thorough workup than is sometimes provided, particularly by direct-to-consumer telehealth platforms that may prescribe testosterone without investigating why levels are low.
Causes Specific to or More Common in Young Men
Obesity and metabolic dysfunction: Excess visceral fat increases aromatase activity, converting testosterone to estrogen, and impairs hypothalamic GnRH secretion through mechanisms related to insulin resistance and leptin dysregulation. This is probably the most common cause of low testosterone in young men in Western countries. The solution is weight loss, not TRT, and weight loss often restores testosterone to normal without medication.
Opioid use: Opioids suppress GnRH release at the hypothalamic level, producing secondary hypogonadism. Prescription opioids for chronic pain, illicit opioids, and high-dose buprenorphine all have this effect. A young man on opioids with low testosterone has opioid-induced hypogonadism, which may be reversible if opioid use can be reduced or stopped, or managed through testosterone replacement if opioids are medically necessary.
Sleep apnea: Obstructive sleep apnea reduces testosterone through two mechanisms: the sleep disruption it causes impairs the overnight testosterone production that depends on normal sleep architecture, and the hypoxic episodes directly suppress Leydig cell function. Treating sleep apnea with CPAP often raises testosterone substantially in affected men.
Anabolic steroid use: Young men who have used anabolic steroids, even briefly, can have prolonged suppression of the HPG axis after stopping. The recovery of natural testosterone production after steroid use takes weeks to months and sometimes requires post-cycle therapy with clomiphene or HCG. A young man with very low LH and FSH along with low testosterone who does not volunteer steroid use history should be asked specifically.
Pituitary pathology: Pituitary adenomas, particularly prolactinomas, can suppress gonadotropin secretion and testosterone in men of any age. Elevated prolactin with low testosterone and low LH in a young man warrants MRI of the pituitary.
Genetic causes: Klinefelter syndrome (47,XXY), the most common chromosomal cause of primary hypogonadism, often presents in men who are not diagnosed until their 20s or 30s. Men with Klinefelter typically have elevated LH and FSH (the pituitary trying to compensate for failing testes), small testicular volume, and may have infertility as the presenting complaint.
Eating disorders and extreme caloric restriction: Male eating disorders are underdiagnosed. Caloric restriction below energy requirements suppresses the HPG axis through a functional mechanism, the brain reduces reproductive signaling when it perceives inadequate energy availability. This is the same mechanism as in female athletes with low energy availability.
The Workup That Should Happen
For a young man with confirmed low testosterone, a complete evaluation should include:
- LH and FSH, to distinguish primary from secondary hypogonadism
- Prolactin, to screen for pituitary prolactinoma
- MRI of the pituitary, if prolactin is elevated or if LH/FSH are low without another explanation
- Testicular examination, clinical and ultrasound if primary hypogonadism is suspected
- Semen analysis, if fertility is a concern
- Chromosome analysis (karyotype), if Klinefelter is suspected (small testes, elevated gonadotropins)
- Assessment of sleep, substance use, dietary patterns, exercise, and stress
- BMI, waist circumference, and fasting glucose/insulin, if obesity is a factor
Why TRT May Not Be the Right First Step
Starting testosterone replacement in a young man without identifying the underlying cause misses an opportunity to address a reversible problem. If obesity is the cause, weight loss restores testosterone. If opioids are the cause, opioid management is the primary intervention. If a pituitary adenoma is the cause, treating the tumor may restore natural testosterone production.
Additionally, TRT suppresses spermatogenesis, a significant concern for young men who have not completed family planning. Starting TRT in a 28-year-old without discussing fertility implications is not appropriate clinical practice.
Clomiphene citrate, which stimulates the HPG axis rather than replacing testosterone, preserves fertility and is often the more appropriate first approach in young men with secondary hypogonadism. This is covered in detail in Clomiphene for Low Testosterone: An Alternative to TRT.
For the full diagnostic framework for hypogonadism, see What Is Hypogonadism? Primary vs. Secondary Explained. For fertility-specific considerations, see Testosterone and Fertility: What TRT Does to Sperm Production.
